Asthma
COPD
Pulmonary
Pulmonary: Page 5
The pulmonary ‘superpower’ of mice
How cutting-edge 3D video images of mouse lung tissue could lead to lung disease treatment in premature babies.
February 27, 2025
Delivery concept for inhalable medicines targets multiple respiratory conditions
Proposed system maps distribution within the lungs.
February 27, 2025
What fuels aggressive lung cancer?
Small cell lung cancer has the ability to create intrinsic energy source that advances tumor growth.
February 26, 2025
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
Nasal COVID-19 vaccine to begin U.S. clinical trials
The FDA has approved an investigational new drug application for the vaccine.
February 19, 2025
Rise in TB cases, clinical trial results
Investigators reveal three new and improved methods to treat drug-resistant tuberculosis.
February 12, 2025
Uncovering another piece of the pulmonary fibrosis puzzle
Gene profiling can help scientists identify — and treat — deadly disease earlier and more efficiently.
February 12, 2025
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
What do copper and lung cancer have in common?
A newly developed copper sensing probe could be first step in chelation therapy.
February 7, 2025
Winrevair trial reaches primary endpoints early
Merck ends Hyperion trial of pulmonary arterial hypertension to focus on final analysis.
February 7, 2025
How to train lung disease diagnoses
Artificial intelligence model identifies respiratory disorders with 97% accuracy.
January 30, 2025
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
COVID-19 analysis opens door to future pulmonary fibrosis treatment
Groundbreaking research sheds light on potential strategies to reduce or repair damage from lung disease.
January 30, 2025
European Commission approves new first-line treatment for NSCLC
Lazertinib-amivantamab combination therapy shows success compared to current standard of care.
January 29, 2025
Hyperuricemia could contribute to PAH
Analysis suggests high uric acid levels could be an important risk factor for pulmonary arterial hypertension.
January 29, 2025
Previous Page
Page 5 of 20
Next Page
Most Popular
CHEST publishes new guideline on NSCLC management
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Study points toward potential screening test for COPD
Telehealth, home oxygen therapy could reduce readmissions in COPD patients
Language barriers linked to poorer asthma outcomes
Ethris launches phase 2a clinical trial of mRNA candidate for asthma